en · de · es · fr · pt
faq-desk.peptides6155.com › News › Background And Receptor Pharmacology — Questions and Answers

Background And Receptor Pharmacology — Questions and Answers

By Editorial Desk · published 2025-08-24 · last reviewed 2025-09-28 · News

research chemical raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2025-09-28. Anything still debated is marked as such rather than presented as settled.

Background and Receptor Pharmacology

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.

Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.

Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.

Background and Pharmacological Mechanism

Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.

SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic REV-ERB agonistBinds REV-ERBα and REV-ERBβ in preclinical models
Molecular formulaC20H24ClN3O4SReported for the parent compound
CAS Registry Number1379686-30-2Common identifier in chemical databases
AppearanceOff-white to pale yellow solidTypical research chemical solid
SolubilitySoluble in DMSO and ethanol; low in waterClass: small organic molecule

Analytical and Handling Considerations

For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.

Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.

SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.

Related pages on this site

Detection, Regulation, and Misconceptions

Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.

Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.

Handling Storage and Quality Control

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.

Background from the literature

=== Pharmacodynamics === Clascoterone is a steroidal antiandrogen, or antagonist of the androgen receptor (AR), the biological target of androgens such as testosterone and dihydrotestosterone (DHT). In a bioassay, the topical potency of the medication was greater than that of progesterone, flutamide, and finasteride and was equivalent to that of cyproterone acetate. Likewise, it is significantly more efficacious as an antiandrogen than other AR antagonists such as enzalutamide and spironolactone in scalp dermal papilla cells and sebocytes in vitro.

Trends in obesity prevalence show no increase among youth since 2003–2004, but trends do show increases in both adults and youth from 1999 to 2000 through 2013–2014. No significant differences between 2011 and 2012 and 2013–2014 were seen in either youth or adults. Under pressure from parents and anti-obesity advocates, many school districts moved to ban sodas, junk foods, and candy from vending machines and cafeterias. State legislators in California, for example, passed laws banning the sale of machine-dispensed snacks and drinks in elementary schools in 2003, despite objections by the California-Nevada Soft Drink Association. The state followed more recently with legislation to prohibit their soda sales in high schools starting July 1, 2009, with the shortfall in school revenue to be compensated by an increase in funding for school lunch programs. A similar law passed by the Connecticut General Assembly in June 2005 was vetoed by governor Jodi Rell, who stated the legislation "undermines the control and responsibility of parents with school-aged children." In mid-2006, the American Beverage Association (including Cadbury, Coca-Cola, and PepsiCo) agreed to a voluntary ban on the sale of all high-calorie drinks and all beverages in containers larger than 8, 10 and 12 ounces in elementary, middle and high schools, respectively. There have been many strategies to try to control obesity issues. One cost-effective population-level change is taxes on sugary drinks. Interventions such as taxes can be a powerful way to improve the economic landscape of the food environment.

=== Loading === At the beginning of the run, a mixture of solutes to be separated is applied to the column, under conditions selected to promote high retention. The higher-affinity solutes are preferentially retained near the head of the column, with the lower-affinity solutes moving farther downstream. The fastest moving component begins to form a pure zone downstream. The other components also begin to form zones, but the continued supply of the mixed feed at head of the column prevents full resolution.

Cycling between supercritical and subcritical CO2 at tectonic fault zones might have led to peptides integrating with and stabilizing lipid membranes. This is suggested to have driven membrane protein evolution, as it shown that a selected peptide (H-Lys-Ser-Pro-Phe-Pro-Phe-Ala-Ala-OH) causes the increase of membrane permeability to water. David Deamer and Bruce Damer states that the prebiotic chemistry does not require ultraviolet irradiation as the chemistry could also have occurred under shaded areas that protected biomolecules from photolysis.

Sources: en.wikipedia.org

Further detail

Gambia: Diplomat Serign Modou Njie called on international law to be respected "without exceptions". Ghana: Foreign Minister Samuel Okudzeto Ablakwa spoke against America's actions, stating the strikes were colonial and imperialist in nature, stating they had "no place" in the current world order. Kenya: The nation did not release their own statement, instead opting to back the African Union's statement of concern of the action, stressing the territorial integrity and self-determination of Venezuelans. Liberia: Minister of Foreign Affairs Sara Beysolow Nyanti stated that action should be taken at the United Nations Security Council to further discuss the strikes. Mali: Minister of Foreign Affairs Abdoulaye Diop condemned the strikes, specifically naming those on military and civilian targets. Namibia: The Ministry of International Relations and Trade stated that the strikes had violated Venezuela's sovereignty and international law, further calling for a meeting of the United Nations Security Council to sort out the matter. The decision by Namibia, a nation which traditionality voiced anti-imperialism, to not explicitly condemn the strikes was pointed out as a change in their traditional rhetoric by Deutsche Welle. Niger: Minister of Forign Affairs Yaou Sangaré Bakary stated the situation constituted a threat to peace and stability on the South American continent.

The basis for its observance is found in the Torah of the Hebrew Bible, in Genesis chapter 17, in which a covenant of circumcision is made with Abraham and his descendants. God states circumcision is "a sign of the covenant between me and you". Jewish circumcision is part of the brit milah ritual, to be performed by a trained ritual circumciser, a mohel, on the eighth day of a newborn son's life, with certain exceptions for poor health. Jewish law requires that circumcision leaves the glans bare when the penis is flaccid. Mainstream Judaism foresees serious negative spiritual consequences if it is neglected.

An aboriginal Australian fable, retold by the Welsh school headmaster William Jenkyn Thomas (1870–1959), tells how some animals needed a canoe to cross the ocean. Whale had one but refused to lend it, so Starfish kept him busy, telling him stories and grooming him to remove parasites, while the others stole the canoe. When Whale realized the trick he beat Starfish ragged, which is how Starfish still is today. In 1900, the scholar Edward Tregear documented The Creation Song, which he describes as "an ancient prayer for the dedication of a high chief" of Hawaii. Among the "uncreated gods" described early in the song is the starfish. Georg Eberhard Rumpf's 1705 The Ambonese Curiosity Cabinet describes the tropical varieties of Stella Marina or Bintang Laut, "Sea Star" in Latin and Malay respectively, known in the waters around Ambon. He writes that the Histoire des Antilles reports that when the sea stars "see thunder storms approaching, [they] grab hold of many small stones with their little legs, looking to ... hold themselves down as if with anchors".

== Biological significance and applications == Imidazole is incorporated into many important biological compounds. The most pervasive is the amino acid histidine, which has an imidazole side-chain. Histidine is present in many proteins and enzymes, e.g. by binding metal cofactors, as seen in hemoglobin. Imidazole-based histidine compounds play an important role in intracellular buffering. Histidine can be decarboxylated to histamine. Histamine can cause urticaria (hives) when it is produced during allergic reaction.

== Legislative impact == In February 2025, West Virginia lawmakers introduced House Bill 2789, also known as The Michael Brandon Cochran Act. The bill mandates intensive care units to conduct C-peptide insulin tests for unconscious patients or those presenting with hypoglycemia and blood glucose levels below 49 mg/dl. The legislation aims to prevent similar cases of insulin misuse.

Sources: en.wikipedia.org

Supporting material

The working group defined four criteria that must be fulfilled: "like-mindedness", "significant player", "mutual benefit" and "global considerations." The working group's recommendations were presented at the OECD Ministerial Council Meeting on 13 May 2004, and on 16 May 2007, the OECD Ministerial Council decided to open accession discussions with Chile, Estonia, Israel, Russia, and Slovenia, and to strengthen cooperation with Brazil, China, India, Indonesia, and South Africa through a process of enhanced engagement. Chile, Slovenia, Israel, and Estonia all became members in 2010. In March 2014, the OECD halted membership talks with Russia in response to its annexation of Crimea. In 2013, the OECD decided to open membership talks with Colombia and Latvia. In 2015, the Organisation opened talks with Costa Rica and Lithuania. Latvia became a member on 1 July 2016, and Lithuania soon followed on 5 July 2018. Colombia signed the accession agreement on 30 May 2018 and became a member on 28 April 2020. On 15 May 2020, the OECD decided to extend a formal invitation for Costa Rica to join the OECD, which joined as a member on 25 May 2021. Other countries that have expressed interest in OECD membership are Argentina, Brazil, Croatia, Malaysia and Peru. In January 2022, the OECD reported that membership talks were underway with Argentina, Brazil, Bulgaria, Croatia, Peru and Romania. In March 2022, the OECD suspended the participation of Russia and Belarus due to the ongoing Russian invasion of Ukraine.

Conjugated proteins carry out a wide variety of biological functions that are very important to the survival of living organism, all of which are highly dependent of the chemical structure of the prosthetic group. Transport is one of the most important roles of conjugated proteins. Hemoproteins are a type of conjugate proteins that help facilitate the transportation of oxygen in blood. Another example of a conjugate protein is lipoproteins. Lipoproteins help facilitate the transportation of lipids like cholesterol and triglycerides. These conjugate proteins help with transportation and are very important in maintaining cellular metabolism and energy levels. Conjugated proteins are equally important for enzymatic functions as enzymes require prosthetic groups to function. Metalloproteins are an example where metal ions assist in stabilizing intermediates and transferring electrons. Another example includes flavoproteins. Flavoproteins help facilitate oxidation-reduction reactions by utilizing molecules derived from vitamins. Regulation is another important function of conjugated proteins. Phosphoproteins facilitate reversible phosphorylation reactions which are important in the regulation of cellular functions and protein activity. Phosphorylation allows cells to quickly respond to different environmental factors by switching on and off selected proteins.

=== HAP2 family === HAP2 is a fusexin (similar to viral class II) found in diverse eukaryotes including Toxoplasma, vascular plants, and fruit flies. This protein is essential for gamete fusion in these organisms. Its origin is unclear, as the broader grouping of fusexins could be older than the viral class II with the discovery of archaeal homologs.

The lower respiratory tract is part of the respiratory system, and consists of the trachea and the structures below this including the lungs. The trachea receives air from the pharynx and travels down to a place where it splits (the carina) into a right and left primary bronchus. These supply air to the right and left lungs, splitting progressively into the secondary and tertiary bronchi for the lobes of the lungs, and into smaller and smaller bronchioles until they become the respiratory bronchioles. These in turn supply air through alveolar ducts into the alveoli, where the exchange of gases take place. Oxygen breathed in, diffuses through the walls of the alveoli into the enveloping capillaries and into the circulation, and carbon dioxide diffuses from the blood into the lungs to be breathed out. Estimates of the total surface area of lungs vary from 50 to 75 square metres (540 to 810 sq ft); although this is often quoted in textbooks and the media being "the size of a tennis court", it is actually less than half the size of a singles court. The bronchi in the conducting zone are reinforced with hyaline cartilage in order to hold open the airways. The bronchioles have no cartilage and are surrounded instead by smooth muscle. Air is warmed to 37 °C (99 °F), humidified and cleansed by the conducting zone. Particles from the air being removed by the cilia on the respiratory epithelium lining the passageways, in a process called mucociliary clearance.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.

Is SR9009 a hormone?

No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.

What is known about human use?

Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.

What is SR9009?

It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.

Network